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Purpose: Video capsule endoscopy (VCE) is a procedure that uses a wireless camera 
to take pictures of the gastrointestinal (GI) tract. A wireless motility capsule (WMC) of a 
similar size has been developed, which measures pH, pressure, and temperature and 
can be used to assess regional and total GI transit times. VCE could also potentially be 
used as a tool for measuring small bowel transit time (SBTT).
Methods: This study was designed to obtain SBTT from VCE and compare it with his-
torical data generated by WMC. Gastric transit time (GTT) was also measured. Patients 
were included if the indication for VCE was either iron deficiency anemia (IDA) or overt 
obscure GI bleed (OOGIB), and they did not have any known motility disorder. Results 
from VCE were also compared in diabetic vs. non-diabetic patients.
results: There were a total of 147 VCE studies performed, including 42 for OOGIB and 
105 for IDA. Median GTT and SBTT were 0.3 and 3.6 h, respectively. The overall median 
GTT and SBTT were 0.3 and 3.6 h, respectively, in the IDA group compared with 0.3 and 
3.4 h in the OOGIB group. When compared with WMC, the GTT and SBTT were signifi-
cantly faster in both groups (GTT: 3.6 h and SBTT: 4.6 h). The median GTT and SBTT 
were not significantly different in diabetics vs. non-diabetics [GTT: 17.5 vs. 18.0  min 
(P = 0.86) and SBTT: 3.9 h (237 min) vs. 3.8 h (230 min), respectively (P = 0.90)].
conclusion: SBTT as measured using VCE is not significantly different in OOGIB com-
pared with IDA. Both GTT and SBTT are significantly faster as assessed by VCE, which 
is initiated in the fasting state, compared with WMC measurement, which is initiated after 
a standard meal. In summary, VCE could potentially be used for measuring SBTT in the 
fasting state.
Keywords: video capsule endoscopy, small intestine transit time, wireless motility capsule
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inTrODUcTiOn
Studying small bowel transit time (SBTT) is complex because of 
the anatomical organization of this organ. While the transit time 
and motility patterns of the small intestine are less appreciated 
compared with other segments of the gastrointestinal (GI) tract 
in our clinics, assessment of these parameters might be helpful in 
patients with pseudo-obstruction, abdominal pain of unknown 
cause, a number of metabolic disorders, and possibly small intes-
tinal bacterial overgrowth (SIBO) (1, 2).
Available tools for the assessment of small intestinal motility 
are suffering from several limitations making them inaccurate 
for both clinical and research purposes. Among them, the oldest 
method, i.e. radiographic barium study or small bowel follow-
through, provides structural information without an accurate 
transit measurement. Small intestinal manometry can only 
study the upper part of the small intestine. Moreover, with this 
technique, the insertion of the catheter may interfere with the 
physiologic motility patterns. Radiopaque markers are mainly 
suitable for the study of colonic and whole gut transit. Hydrogen 
breath test measures orocecal transit time rather than the pure 
small intestinal transit time, and its results may be misinterpreted 
in the presence of SIBO (1, 3).
Scintigraphic methods, involving isotope-labeled liquids or 
meals, expose the patients to radiation and their accuracy in 
the measurement of SBTT is affected by the gastric emptying 
component.
Wireless motility capsule (WMC), which uses changes in pH 
as the landmarks, is currently the method of choice for studying 
the SBTT. The capsule is ingested immediately after consuming 
a calorie meal in order to induce a “fed state” setting. In 5–10% 
of cases, the determination of SBTT is not possible with this 
technique due to difficulties in interpretation of entrance into the 
cecum (4). Moreover, WMC has demonstrated different transit 
values based on age, gender, and country where the study is 
performed and testing protocol (5).
On the other hand, video capsule endoscopy (VCE), which 
provides visualization of the GI tract through wireless transmis-
sion of images from a disposable capsule to a data recorder worn 
by the patient, enables us to observe the luminal surface of the 
small intestine and to also study small transit time. As opposed 
to the standard endoscopy procedures, the images do not come 
from a camera being driven into the digestive tract, but rather 
images that are captured as the capsule is carried by peristalsis 
through the gut. The first capsule model for the small intestine 
was approved by the Food and Drug Administration (FDA) in 
2001. VCE is mainly a modality to diagnose small intestinal 
pathology (6–10). This essentially gives a direct examination of 
the entire length of the small bowel in a non-invasive manner (6, 
8, 11). Moreover, small intestinal water content and intraluminal 
secretion as the lubricators of the tract can be studied with this 
method making it a suitable tool in both clinical and research 
settings (12).
Here, we hypothesize that although VCE was essentially 
designed to find organic abnormalities in the small intestine, the 
time elapsed from its entrance to the duodenum to its appearance 
in the cecum may be measured as small intestinal transit time. 
To test our hypothesis, SBTT was analyzed in a group of patients 
without GI motility symptoms in whom VCE were performed and 
then compared with data from historical healthy control subjects 
who have undergone WMC studies. In addition, we measured 
gastric transit time (GTT), which can be a confounding variable 
for assessing SBTT with the VCE method.
MaTerials anD MeThODs
Our study protocol was approved by the Institutional Review 
Board for the Protection of Human Subjects at Texas Tech 
University Health Sciences Center at El Paso, TX, USA.
Measurement of the gi Transit Times
This study included 147 patients with obscure overt GI bleed-
ing (OOGIB) or unexplained iron deficiency anemia (IDA) 
with capsule endoscopy (PillCam, Given Imaging Ltd., Israel). 
These patients had no history of any GI motility disorder. GTT 
and SBTT were measured. Results from VCE were then com-
pared with WMC (SmartPill) published data from 66 healthy 
controls (13).
All patients had at least one negative upper and lower GI 
endoscopy before being referred for VCE examination. Exclusion 
criteria were confirmed or suspicion of GI motility disorders and 
the use of medications, which affect GI transit.
Before the VCE study, each patient was fasted overnight. 
Two hours after swallowing the video-capsule, patients were 
allowed to drink clear liquids and after 4 h, they were allowed 
to eat a light lunch. All VCE were reviewed by an expert (MZ) 
using the PillCam SB® capsule endoscopy system (Given 
Imaging Ltd.). Images were viewed using the Rapid Reader 
(version 3.1) using either a single view or dual view mode, 
which had a maximal speed of 40  frames/s. Each VCE was 
analyzed for GTT and SBTT. The GTT was defined as the time 
of the first gastric image to the first duodenal image. SBTT was 
defined as the time from the first duodenal image to the first 
cecal image.
As mentioned above, GTT and SBTT values for patients with 
OOGIB, IDA, and the overall group (patients who had either 
OOGIB or IDA) were compared with the published transit 
values for the WMC method from 66 healthy controls that were 
reported by Sarosiek et al. (13). In that study, WMC was swal-
lowed after ingestion of a standardized meal of 120 g Eggbeaters 
radiolabeled with technetium 99m sulfur colloid, two pieces of 
bread with jam, and an additional 120-cc of water (total calorie: 
255 kcal). Subjects completed the meal within 10 min, and the 
capsule was ingested immediately after with up to 50 cc water. 
Patients had previously been fasting overnight. Pressure, pH, 
and temperature were continuously measured by the capsule and 
recorded by a portable receiver worn on the waist or suspended 
on a lanyard placed around the neck. None of the subjects had 
dyspeptic symptoms or known gastroparesis, and none of them 
had suspected obstruction or any other reason for prolonged 
capsule transit times (13).
TaBle 1 | characteristics of 147 patients with overt obscure 
gastrointestinal (gi) bleeding (OOgiB) or iron deficiency anemia/occult 
obscure gi bleeding (iDa) who underwent video capsule endoscopy.
characteristic OOgiB 
(n = 42)
iDa 
(n = 105)
all (n = 147) P (OOgiB 
vs. iDa)
Age (years)a 57.0 (13.8) 58.2 (14.4) 57.9 (14.2) 0.66
Race/ethnicityb 1.0
 Hispanic 39 (92.9) 96 (91.4) 135 (91.8)
 Non-Hispanic White 3 (7.1) 7 (6.7) 10 (6.8)
 Black 0 (0) 2 (1.9) 2 (1.4)
Genderb <0.0001
 Female 15 (35.7) 79 (75.2) 94 (64.0)
 Male 27 (64.3) 26 (24.8) 53 (36.1)
SBTT (h)a 3.7 (1.7) 3.8 (1.6) 3.8 (1.6) 0.70
n = 34 n = 87 n = 121
aMean (SD).
bNumber (percent).
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statistical analysis
Data were analyzed using SAS 9.3 software (SAS Institute, Inc., 
Cary, NC, USA) and OpenEpi (Open Source Epidemiologic 
Statistics for Public Health) Version 3.03a (www.openepi.com). 
Patients whose indication for capsule endoscopy was OOGIB 
were compared with those whose indication was IDA. Differences 
in the distributions of age, race/ethnicity, gender, and SBTT by 
indication were compared using a two-sample t-test, chi-square 
test, or Fisher’s exact test as appropriate. Results were considered 
statistically significant if the P-value was 0.05 or less.
A Pearson correlation coefficient was calculated to determine 
the strength of the association between GTT and SBTT. The null 
hypothesis was that rho, the correlation coefficient in the popula-
tion, was 0. The null hypothesis was rejected if the P-value was 
0.05 or less. Two multiple linear regression models were fit. In 
the first model, the outcome variable was GTT, while SBTT was 
the outcome in the second model. Patients who had a missing 
value for GTT were excluded from the regression analysis of 
SBTT. Four independent variables were entered in the regres-
sion models: indication (OOGIB vs. IDA), age (a continuous 
variable), gender, and race/ethnicity (entered using two dummy 
variables). Tolerances were calculated to determine if collinearity 
was present.
Sarosiek et al. (13) reported median rather than mean transit 
values. They also reported the 25th and 75th percentiles, thereby 
allowing the calculation of the interquartile range (75th percen-
tile − 25th percentile). We assumed that the GTT and SBTT of 
the 66 historical controls followed bell-shaped distributions. This 
assumption allowed us to treat the medians that were reported 
by Sarosiek et  al. as means and calculate the SD of the transit 
statistic using the well-known relationship, SD =  interquartile 
range/1.35. Once the SDs were calculated from the results pub-
lished by Sarosiek et al., two-sample t-tests were then performed 
comparing our mean GTT and SBTT values with the published 
historical data. A significance level of 0.05 was specified.
Within our patient population, median GTT and SBTT values 
in diabetics were compared to their respective values in the non-
diabetics using Wilcoxon two-sample tests with a significance 
level of 0.05.
resUlTs
Transit Time Measured by Vce
There were a total of 147 VCE studies performed, including 42 
for OOGIB and 105 for IDA. Mean age (±SD) in the VCE group 
was 57.9 ±  14.2 years. Ninety-four (64%) patients were female 
and 135 (92%) were Hispanic. Demographic characteristics of the 
studied patients are shown in Table 1. Based on VCE, no patient 
had active bleeding.
The video endoscopy capsule did not reach the duodenum 
by the end of the study in 8 of 147 patients (5.4%). The capsule 
reached the cecum in 121/147 (82.3%) of patients. Therefore, 
GTT and SBTT were analyzed in 139 and 121 patients, respec-
tively (Figure 1).
Selected patient characteristics by indication are presented 
in Table 1. Approximately 36% of the OOGIB group vs. 75.2% 
of the IDA group were females (P < 0.0001). In multiple linear 
regression analyses, no associations were detected between the 
outcomes of GTT and SBTT and the following four predictors: 
indication for VCE (OOGIB vs. IDA), age, race/ethnicity, and 
gender. There was a weak inverse linear association between GTT 
and SBTT among the 121 patients for whom both values were 
available (r = −0.19, P = 0.04).
Of those with available information regarding their diabetic 
status (i.e., 40 diabetics vs. 87 non-diabetics), the median GTT 
values were 17.5 min and 18.0 min, respectively (Wilcoxon two-
sample test P =  0.86). For SBTT, 37 diabetics were compared 
with 83 non-diabetics. The median SBTT values in diabetics and 
non-diabetics were 237.0 and 230.0 min, respectively (Wilcoxon 
two-sample test P = 0.90).
The comparison between Vce and WMc
Median GTT measured by WMC was 3.6 h, while median SBTT 
was 4.6  h when measured by WMC (Table  2). Median GTT 
measured by VCE (in all patients combined) was significantly 
faster than when measured by WMC (0.3 vs. 3.6 h, P < 0.0001). 
Median SBTT as measured by VCE (in all patients combined) 
was also significantly faster compared with WMC (3.6 vs. 4.6 h, 
P = 0.0005) (Table 2).
DiscUssiOn
The assessment of GI transit time with VCE has always been of 
interest and is noted on all procedure reports. In this study, we 
have shown that capsule endoscopy, which is mainly indicated for 
the visualization of small intestinal pathology, may alternatively 
be used for the measurement of SBTT. GTT and SBTT using VCE 
were not significantly different in OOGIB patients compared with 
IDA. However, both GTT and SBTT were significantly faster with 
VCE compared with WMC measurements.
Since there were no difference in the GI transit times between 
patients with OOGIB and those with IDA, and they had no known 
GI motility disorder, these patients could be considered as similar 
to healthy control population from a motility perspective. The 
difference between transit times measured by VCE and WMC is 
TaBle 2 | gastric (gTT) and small bowel (sBTT) transit times measured 
by video capsule endoscopy (Vce) compared to wireless motility capsule 
(WMc) historical values retrieved from a study by sarosiek et al.
Transit time (h) Vce WMc  
(hc)
OOgiB iDa all
GTT Number of patients 41 98 139 66
Median (25th percentile, 
75th percentile)
0.3 (0.2, 
0.8)†
0.3 (0.2, 
0.5)†
0.3 (0.2, 
0.6)†
3.6 (3.0, 
4.2)
SBTT Number of patients 34 87 121 66
Median (25th percentile, 
75th percentile)
3.4 (2.4, 
4.9)††††
3.6 (2.6, 
4.9)†††
3.6 (2.5, 
4.9)††
4.6  
(4.0, 5.9)
HC, healthy control; IDA, iron deficiency anemia; OOGIB, obscure-overt gastrointestinal 
bleeding.
†P < 0.0001 for the comparison of OOGIB with HC, IDA with HC, and All with HC.
††P = 0.0005 for the comparison of All with HC.
†††P = 0.001 for the comparison of IDA with HC.
††††P = 0.003 for the comparison of OOGIB with HC.
P-values are from two-sample t-tests comparing means rather than medians  
(see Statistical Analysis for details).
FigUre 1 | Flow diagram of patients included for gastric transit time (gTT) and small bowel transit time (sBTT) analysis.
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most likely explained by the different patients’ statuses, namely 
fasting vs. fed. VCE is performed in the fasting state when phase 
III migratory motor complexes regularly sweep the GI tract, 
while WMC is performed after a standardized solid meal where 
initiation of the migratory motor complex is delayed until gastric 
emptying of solids is achieved (14).
In a previous study from Spain on VCE that measured transit 
times in 89 patients, the mean GTT was approximately 23 min, 
while the mean SBTT was 283 min. No significant associations 
were found between gastric and intestinal transit times with the 
age and sex of studied subjects (15). VCE-recorded GTT (18 min) 
and SBTT (216 min) in our study are in the ranges reported in the 
above-mentioned study.
In another study which was designed to investigate the effect 
of different bowel preparations on GTT and SBTT measured by 
VCE, the median GTT was 25, 34.7, and 35 min among patients 
who were prepared with liquid diet, sodium phosphate, and 
polyethylene glycol, respectively. Mean SBTT among patients 
prepared with liquid diet, sodium phosphate, and polyethylene 
glycol was 264.4, 296.7, and 291.3 min, respectively. Again, GTT 
and SBTT values in this study were similar to our findings (16). In 
the same study, the capsule reached the cecum in approximately 
83.6% of the studied patients. This is also in agreement with our 
study, as in 82.3% of our patients, the capsule reached the cecum 
and we could successfully measure SBTT (16).
Another retrospective study analyzed the association between 
the diagnostic yield of small bowel VCE and the SBTT. Based 
on this study, the cecum was reached in 82% of all procedures 
(17). Although all patients had received prokinetics before the 
procedure, the overall median small SBTT was 246  min (17), 
which was again in agreement with the findings of our study.
Current examinations done with extended battery-life cap-
sules of 12 h have higher success rates in reaching the cecum.
The transit times measured by VCE in diabetic vs. non-
diabetic patients have not been consistent in different studies. 
While we showed no difference between SBTT and GTT values 
in diabetics vs. non-diabetics, based on Triantafyllou et al., on the 
one hand, GTT was significantly longer in patients with diabetes 
compared with non-diabetic patients. On the other hand, SBTT 
was significantly shorter in diabetic compared with non-diabetic 
controls. Cecum was reached in 69 and 89.6% of the diabetic and 
non-diabetic patients, respectively (18). The difference between 
these two studies can be explained by the exclusion of patients 
with symptoms of a motility disorders in our study. Moreover, a 
large proportion of patients (13 out of 29) were excluded from the 
SBTT analysis in the above-mentioned study (18) and may have 
affected the findings of a faster SBTT in diabetic patients. Another 
important factor is the glucose level and the degree of diabetic 
control (HBA1c) in these patients. This data was not available 
on the day which patients had their VCE study. Alternatively, 
our study might lack sufficient statistical power to differentiate 
diabetic and non-diabetic patients.
Our study has some limitations. We used historical healthy 
controls for WMC transit measurement and obscure GI bleeding/
IDA patients to approximate healthy controls for VCE measure-
ment. Therefore, prospective-controlled studies using both WMC 
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and VCE in a multicenter setting would be a more optimal design 
to draw more definite conclusions regarding the segmental transit 
times.
Based on our data and the body of literature, VCE could 
potentially be used for the measurement of SBTT in the fasting 
state. Although our studied population did not have any known or 
suspected motility disorder, validation of the method in healthy 
controls should be pursued.
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